<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns="http://purl.org/rss/1.0/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
   xmlns:dcterms="http://purl.org/dc/terms/"

>
<channel rdf:about="http://www.citeulike.org/about">
<pubDate>Thu, 21 Aug 2008 05:33:07 BST</pubDate>


	<title>CiteULike: omalbam's Macmullen</title>
	<description>CiteULike: omalbam's Macmullen</description>


	<link>http://www.citeulike.org/user/omalbam/author/Macmullen</link>
	<dc:publisher>CiteULike.org</dc:publisher>
	<dc:language>en-gb</dc:language>
	<dc:rights>Copyright &#169; 2004-2008 citeulike.org</dc:rights>
	<items>
    <rdf:Seq>
        <rdf:li rdf:resource="http://www.citeulike.org/user/omalbam/article/2223120"/>

	</rdf:Seq>
	</items>
	</channel>


<item rdf:about="http://www.citeulike.org/user/omalbam/article/2223120">
    <title>Accuracy of [18F]Fluorodopa Positron Emission Tomography for Diagnosing and Localizing Focal Congenital Hyperinsulinism</title>
    <link>http://www.citeulike.org/user/omalbam/article/2223120</link>
    <description>&lt;i&gt;J Clin Endocrinol Metab, Vol. 92, No. 12. (1 December 2007), pp. 4706-4711.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Objectives: Focal lesions in infants with congenital hyperinsulinism (HI) represent areas of adenomatosis that express a paternally derived ATP-sensitive potassium channel mutation due to embryonic loss of heterozygosity for the maternal 11p region. This study evaluated the accuracy of 18F-fluoro-L-dihydroxyphenylalanine ([18F]DOPA) positron emission tomography (PET) scans in diagnosing focal vs. diffuse disease and identifying the location of focal lesions. Design: A total of 50 infants with HI unresponsive to medical therapy were studied. Patients were injected iv with [18F]DOPA, and PET scans were obtained for 5060 min. Images were coregistered with abdominal computed tomography scans. PET scan interpretations were compared with histological diagnoses. Results: The diagnosis of focal or diffuse HI was correct in 44 of the 50 cases (88%). [18F]DOPA PET identified focal areas of high uptake of radiopharmaceutical in 18 of 24 patients with focal disease. The locations of these lesions matched the areas of increased [18F]DOPA uptake on the PET scans in all of the cases. PET scan correctly located five lesions that could not be visualized at surgery. The positive predictive value of [18F]DOPA in diagnosing focal adenomatosis was 100%, and the negative predictive value was 81%. Conclusions: [18F]DOPA PET scans correctly diagnosed 75% of focal cases and were 100% accurate in identifying the location of the lesion. These results suggest that [18F]DOPA PET imaging provides a useful guide to surgical resection of focal adenomatosis and should be considered as a guide to surgery in all infants with congenital HI who have medically uncontrollable disease. 10.1210/jc.2007-1637</description>
    <dc:title>Accuracy of [18F]Fluorodopa Positron Emission Tomography for Diagnosing and Localizing Focal Congenital Hyperinsulinism</dc:title>

    <dc:creator>Olga Hardy</dc:creator>
    <dc:creator>Miguel Hernandez-Pampaloni</dc:creator>
    <dc:creator>Janet Saffer</dc:creator>
    <dc:creator>Joshua Scheuermann</dc:creator>
    <dc:creator>Linda Ernst</dc:creator>
    <dc:creator>Richard Freifelder</dc:creator>
    <dc:creator>Hongming Zhuang</dc:creator>
    <dc:creator>Courtney Macmullen</dc:creator>
    <dc:creator>Susan Becker</dc:creator>
    <dc:creator>Scott Adzick</dc:creator>
    <dc:creator>Chaitanya Divgi</dc:creator>
    <dc:creator>Abass Alavi</dc:creator>
    <dc:creator>Charles Stanley</dc:creator>
    <dc:identifier>doi:10.1210/jc.2007-1637</dc:identifier>
    <dc:source>J Clin Endocrinol Metab, Vol. 92, No. 12. (1 December 2007), pp. 4706-4711.</dc:source>
    <dc:date>2008-01-12T18:37:49-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>J Clin Endocrinol Metab</prism:publicationName>
    <prism:volume>92</prism:volume>
    <prism:number>12</prism:number>
    <prism:startingPage>4706</prism:startingPage>
    <prism:endingPage>4711</prism:endingPage>
    <prism:category>diagnosis</prism:category>
    <prism:category>hypoglycemia</prism:category>
    <prism:category>pet</prism:category>
</item>



</rdf:RDF>

